Liangyun Weng
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Liangyun Weng has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
Feng Gao
Animal-Derived Food Safety Innovation Team, College of Veterinary Medicine, Anhui Agricultural University
1 shared publicationLin Li
Animal-Derived Food Safety Innovation Team, College of Veterinary Medicine, Anhui Agricultural University
1 shared publicationLinran Fu
Animal-Derived Food Safety Innovation Team, College of Veterinary Medicine, Anhui Agricultural University
1 shared publicationMengying Zhang
Animal-Derived Food Safety Innovation Team, College of Veterinary Medicine, Anhui Agricultural University
1 shared publicationQianyu Ji
Animal-Derived Food Safety Innovation Team, College of Veterinary Medicine, Anhui Agricultural University
1 shared publicationQingjun Xu
Animal-Derived Food Safety Innovation Team, College of Veterinary Medicine, Anhui Agricultural University
1 shared publication
Latest Publications
- Open Access
- 7 May 2025
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 69 (5) , e0180524
NDM-5-carried outer membrane vesicles impair the efficacy of antibiotics against bacterial infections
The intensifying use of antimicrobials in the rapidly growing livestock industry has heightened concerns over the proliferation of antibiotic resistance, particularly among Enterobacteriaceae producing β-lactamase. Elucidating the role of β-lactamase could unlock novel strategies to combat drug-resistant Enterobacteriaceae in livestock and poultry farming. Outer membrane vesicles (OMVs) produced by gram-negative bacteria have the ability to encapsulate and transport components derived from their parental bacteria. This raises the intriguing possibility that OMVs from drug-resistant bacteria could harbor drug-resistance enzymes, thereby conferring protection to susceptible bacteria against antibiotics. Here, we successfully extracted OMVs from New Delhi metallo-β-lactamase-5 (NDM-5)-expressing Escherichia coli and confirmed that these vesicles indeed carry NDM-5 protein. Furthermore, bacterial protection assays showed that these OMVs could cause sensitive bacteria treated with meropenem to restore growth activity, and the degradation of meropenem by the OMVs was verified using high-performance liquid chromatography. Lastly, the survival rate of the OMVs intervention group was significantly lower than that of the drug-treated group in a Galleria mellonella larvae infection model, validating the protective effect of these OMVs on sensitive bacteria and increasing their tolerance to meropenem. These findings illustrate that OMVs can serve as vehicles for resistance-related factors, thereby promoting antibiotic tolerance in susceptible bacteria.
- 7 May 2025
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 69 (5) , e0180524
Open AccessNDM-5-carried outer membrane vesicles impair the efficacy of antibiotics against bacterial infections
The intensifying use of antimicrobials in the rapidly growing livestock industry has heightened concerns over the proliferation of antibiotic resistance, particularly among Enterobacteriaceae producing β-lactamase. Elucidating the role of β-lactamase could unlock novel strategies to combat drug-resistant Enterobacteriaceae in livestock and poultry farming. Outer membrane vesicles (OMVs) produced by gram-negative bacteria have the ability to encapsulate and transport components derived from their parental bacteria. This raises the intriguing possibility that OMVs from drug-resistant bacteria could harbor drug-resistance enzymes, thereby conferring protection to susceptible bacteria against antibiotics. Here, we successfully extracted OMVs from New Delhi metallo-β-lactamase-5 (NDM-5)-expressing Escherichia coli and confirmed that these vesicles indeed carry NDM-5 protein. Furthermore, bacterial protection assays showed that these OMVs could cause sensitive bacteria treated with meropenem to restore growth activity, and the degradation of meropenem by the OMVs was verified using high-performance liquid chromatography. Lastly, the survival rate of the OMVs intervention group was significantly lower than that of the drug-treated group in a Galleria mellonella larvae infection model, validating the protective effect of these OMVs on sensitive bacteria and increasing their tolerance to meropenem. These findings illustrate that OMVs can serve as vehicles for resistance-related factors, thereby promoting antibiotic tolerance in susceptible bacteria.